BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 24161680)

  • 1. Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.
    Hess SM; Young EF; Miller KR; Vincent BG; Buntzman AS; Collins EJ; Frelinger JA; Hess PR
    Transpl Immunol; 2013 Dec; 29(1-4):138-45. PubMed ID: 24161680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the immunodominant HY H2-D(k) epitope and evaluation of the role of direct and indirect antigen presentation in HY responses.
    Millrain M; Scott D; Addey C; Dewchand H; Ellis P; Ehrmann I; Mitchell M; Burgoyne P; Simpson E; Dyson J
    J Immunol; 2005 Dec; 175(11):7209-17. PubMed ID: 16301625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fusion vaccines induce targeted epitope-specific CTLs against minor histocompatibility antigens from a normal or tolerized repertoire.
    Rice J; Buchan S; Dewchand H; Simpson E; Stevenson FK
    J Immunol; 2004 Oct; 173(7):4492-9. PubMed ID: 15383580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers.
    Maile R; Wang B; Schooler W; Meyer A; Collins EJ; Frelinger JA
    J Immunol; 2001 Oct; 167(7):3708-14. PubMed ID: 11564786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of HY response: T cell expansion, immunodominance, and cross-priming revealed by HY tetramer analysis.
    Millrain M; Chandler P; Dazzi F; Scott D; Simpson E; Dyson PJ
    J Immunol; 2001 Oct; 167(7):3756-64. PubMed ID: 11564792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of tyrosine to the inflammation-associated analog 3'-nitrotyrosine at either TCR- or MHC-contact positions can profoundly affect recognition of the MHC class I-restricted epitope of lymphocytic choriomeningitis virus glycoprotein 33 by CD8 T cells.
    Hardy LL; Wick DA; Webb JR
    J Immunol; 2008 May; 180(9):5956-62. PubMed ID: 18424715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of the immune response to mouse non-MHC transplantation antigens in vivo: the H60 histocompatibility antigen dominates over all others.
    Choi EY; Yoshimura Y; Christianson GJ; Sproule TJ; Malarkannan S; Shastri N; Joyce S; Roopenian DC
    J Immunol; 2001 Apr; 166(7):4370-9. PubMed ID: 11254691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral "CD8 tuning" dynamically modulates the size and responsiveness of an antigen-specific T cell pool in vivo.
    Maile R; Siler CA; Kerry SE; Midkiff KE; Collins EJ; Frelinger JA
    J Immunol; 2005 Jan; 174(2):619-27. PubMed ID: 15634879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetramer-blocking assay for defining antigen-specific cytotoxic T lymphocytes using peptide-MHC tetramer.
    Yokouchi H; Chamoto K; Wakita D; Noguchi D; Yamazaki K; Dosaka-Akita H; Nishimura M; Ikeda H; Nishimura T
    Cancer Sci; 2006 Feb; 97(2):148-54. PubMed ID: 16441426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
    Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ
    Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses.
    Belz GT; Stevenson PG; Doherty PC
    J Immunol; 2000 Sep; 165(5):2404-9. PubMed ID: 10946264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of CD8+ T cell response to antigen by the levels of self MHC class I.
    Santori FR; Arsov I; Vukmanović S
    J Immunol; 2001 May; 166(9):5416-21. PubMed ID: 11313378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
    Cheuk E; D'Souza C; Hu N; Liu Y; Lang H; Chamberlain JW
    J Immunol; 2002 Nov; 169(10):5571-80. PubMed ID: 12421934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence for in vivo induction of CD8+ cytotoxic T cells directed to donor MHC class I peptides following mouse allotransplantation.
    Popov IA; Fedoseyeva EV; Orr PL; Garovoy MR; Benichou G
    Transplantation; 1995 Dec; 60(12):1621-4. PubMed ID: 8545902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor antigen distribution predicts site-specific graft-versus-tumor activity of adoptively transferred, minor antigen-specific CD8 T Cells.
    Shand JC; Qin H; Nasholm N; Capitini CM; Fry TJ
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):26-36. PubMed ID: 24141010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response.
    Zarozinski CC; Welsh RM
    J Exp Med; 1997 May; 185(9):1629-39. PubMed ID: 9151900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes.
    Mylin LM; Schell TD; Roberts D; Epler M; Boesteanu A; Collins EJ; Frelinger JA; Joyce S; Tevethia SS
    J Virol; 2000 Aug; 74(15):6922-34. PubMed ID: 10888631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective graft depletion of MiHAg T-cell specificities and consequences for graft-versus-host disease.
    de Witte MA; Toebes M; Song JY; Wolkers MC; Schumacher TN
    Blood; 2007 May; 109(9):3830-8. PubMed ID: 17202318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex class I-peptide complexes.
    Gallimore A; Glithero A; Godkin A; Tissot AC; Plückthun A; Elliott T; Hengartner H; Zinkernagel R
    J Exp Med; 1998 May; 187(9):1383-93. PubMed ID: 9565631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of cytotoxic T lymphocytes by MHC class I ligands fused to heat shock cognate protein 70.
    Udono H; Yamano T; Kawabata Y; Ueda M; Yui K
    Int Immunol; 2001 Oct; 13(10):1233-42. PubMed ID: 11581168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.